| Term | Description | Count | p-Value | Genes |
| Module 1 | | | | | hsa04062 | Chemokine signaling pathway | 8 | 2.85E-09 | CXCL1, CXCR4, CCR1, CCR2, CXCL2, CXCL8, CCL19, CXCR2 | hsa04060 | Cytokine-cytokine receptor interaction | 8 | 1.84E-08 | CXCL1, CXCR4, CCR1, CCR2, CXCL2, CXCL8, CCL19, CXCR2 | hsa05150 | Staphylococcus aureus infection | 4 | 7.22E-05 | C3AR1, C5AR1, FPR1, FPR2 | hsa04080 | Neuroactive ligand-receptor interaction | 4 | 0.008378 | C3AR1, C5AR1, FPR1, FPR2 | hsa05134 | Legionellosis | 3 | 0.003179 | CXCL1, CXCL2, CXCL8 | hsa04621 | NOD-like receptor signaling pathway | 3 | 0.003416 | CXCL1, CXCL2, CXCL8 | hsa05132 | Salmonella infection | 3 | 0.007372 | CXCL1, CXCL2, CXCL8 | Module 2 | | | | | hsa04610 | Complement and coagulation cascades | 2 | 0.058715 | PLAU, PLAUR | Module 3 | | | | | hsa04666 | Fc gamma R-mediated phagocytosis | 5 | 1.03E-07 | LYN, FCGR1A, HCK, FCGR2A, PIK3R2 | hsa04380 | Osteoclast differentiation | 4 | 6.56E-05 | FCGR1A, FCGR2A, FCGR3A, PIK3R2 | hsa05150 | Staphylococcus aureus infection | 3 | 5.96E-04 | FCGR1A, FCGR2A, FCGR3A | hsa05140 | Leishmaniasis | 3 | 0.00103 | FCGR1A, FCGR2A, FCGR3A | hsa04611 | Platelet activation | 3 | 0.003414 | LYN, FCGR2A, PIK3R2 | hsa05322 | Systemic lupus erythematosus | 3 | 0.003624 | FCGR1A, FCGR2A, FCGR3A | hsa04145 | Phagosome | 3 | 0.004524 | FCGR1A, FCGR2A, FCGR3A | hsa05152 | Tuberculosis | 3 | 0.006255 | FCGR1A, FCGR2A, FCGR3A | hsa04062 | Chemokine signaling pathway | 3 | 0.006891 | LYN, HCK, PIK3R2 | hsa04664 | Fc epsilon RI signaling pathway | 2 | 0.048472 | LYN, PIK3R2 | hsa04662 | B cell receptor signaling pathway | 2 | 0.049171 | LYN, PIK3R2 | Module 4 | | | | | hsa04512 | ECM-receptor interaction | 2 | 0.049648 | TNC, SPP1 |
|
|
Notes: Count, the number of DEGs. Abbreviations: DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes; PPI, protein–protein interaction.
|